Plumasの空売り状況は、投資家がPlumasの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Plumas (NASDAQ:PLBC) 株価情報, 空売り情報

Plumas

Plumas Bancorp is a bank holding company that provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.

Plumas Bancorp

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Baird analyst Michael Bellisario initiated coverage on Expedia Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>) with an Outperform rating and announced a price target of $225. Expedia shares closed at $186.28 on Tuesday. <a href="https://www.benzinga.com/quote/EXPE/analyst-ratings">See how other analysts view this stock.</a></li>
<li>TD Cowen analyst Lance Vitanza initiated coverage on Compass Diversified (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CODI#NYSE">CODI</a>) with a Buy rating and announced a price target of $34. Compass Diversified shares closed at $23.55 on Tuesday. <a href="https://www.benzinga.com/quote/CODI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Stephens &amp; Co. analyst Andrew Terrell initiated coverage on Bank of Hawaii Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOH#NYSE">BOH</a>) with an Overweight rating and announced a price target of $90. Bank of Hawaii shares closed at $79.81 on Tuesday. <a href="https://www.benzinga.com/quote/BOH/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird analyst Michael Bellisario initiated coverage on Booking Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>) with an Outperform rating and announced a price target of $5,850. Booking shares closed at $5,214.72 on Tuesday. <a href="https://www.benzinga.com/quote/BKNG/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Stephens &amp; Co. analyst Andrew Terrell initiates coverage on Plumas Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBC#NASDAQ">PLBC</a>) with an Overweight rating and announced a price target of $60. Plumas shares closed at $48.00 on Tuesday. <a href="https://www.benzinga.com/quote/PLBC/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying EXPE stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="478" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27081550/image-295-1024x478.png" alt="" class="wp-image-667316" style="width:683px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27081550/image-295-1024x478.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27081550/image-295-300x140.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27081550/image-295-768x359.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27081550/image-295.png 1178w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This More: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42210452/top-3-consumer-stocks-that-are-set-to-fly-in-q4">Top 3 Consumer Stocks That Are Set To Fly In Q4</a></li>
</ul>

News

Initiation

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

BKNG

CODI

EXPE

PLBC

This Expedia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Stephens &amp; Co. analyst Andrew Terrell initiates coverage on Plumas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBC#NASDAQ">PLBC</a>) with a Overweight rating and announces Price Target of $60.

Price Target

Stephens & Co. Initiates Coverage On Plumas with Overweight Rating, Announces Price Target of $60

Raymond James analyst David Feaster maintains Plumas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBC#NASDAQ">PLBC</a>) with a Outperform and raises the price target from $43 to $45.

Raymond James Maintains Outperform on Plumas, Raises Price Target to $45

Plumas Bancorp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plbc#NASDAQ">PLBC</a>) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, PLBC&#39;s 50-day simple moving average crossed above its 200-day simple moving average, known as a &quot;golden cross.&quot;
A golden cross is a technical chart pattern that can signify a potential bullish breakout. It&#39;s formed from a crossover involving a security&#39;s short-term moving average breaking above a longer-term moving average, with the most common moving averages being the 50-day and the 200-day, since bigger time periods tend to form stronger breakouts.
There are three stages to a golden cross. First, there must be a downtrend in a stock&#39;s price that eventually bottoms out. Then, the stock&#39;s shorter moving average crosses over its longer moving average, triggering a positive trend reversal. The third stage is when a stock continues the upward momentum to higher prices.
This kind of chart pattern is the opposite of a death cross, which is a technical event that suggests future bearish price movement.
Shares of PLBC have been moving higher over the past four weeks, up 22.3%. Plus, the company is currently a #2 (Buy) on the Zacks Rank, suggesting that PLBC could be poised for a breakout.
The bullish case solidifies once investors consider PLBC&#39;s positive earnings outlook. For the current quarter, no earnings estimate has been cut compared to 1 revisions higher in the past 60 days. The Zacks Consensus Estimate has increased too.
<img alt="Moving Average Chart for PLBC" class="chart" src="https://staticx-tuner.zacks.com/images/articles/charts/yseop/549/PLBC_SMA50_200.jpeg" style="height:auto; width:100%" title="" />
With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on PLBC for more gains in the near future.
<a href="https://www.zacks.com/stock/news/2313037/plumas-bancorp-plbc-now-trades-above-golden-cross-time-to-buy?cid=CS-BENZ-FT-tale_of_the_tape|golden_crossover-2313037">To read this article on Zacks.com click here.</a>

Earnings

Technicals

Plumas Bancorp Now Trades Above Golden Cross: Time to Buy?

Plumas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBC#NASDAQ">PLBC</a>) reported quarterly earnings of $1.14 per share which beat the analyst consensus estimate of $1.09 by 4.59 percent. This is a 1.79 percent increase over earnings of $1.12 per share from the same period last year. The company reported quarterly sales of $20.61 million which beat the analyst consensus estimate of $20.00 million by 3.04 percent. This is a 6.32 percent increase over sales of $19.38 million the same period last year.

Plumas Q2 EPS $1.14 Beats $1.09 Estimate, Sales $20.61M Beat $20.00M Estimate

Plumas Bancorp Joins Russell 2000 Index

Plumas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBC#NASDAQ">PLBC</a>) reported quarterly earnings of $1.08 per share which missed the analyst consensus estimate of $1.19 by 9.24 percent. This is a 15.62 percent decrease over earnings of $1.28 per share from the same period last year.

UPDATE: Plumas Q1 2024 Adj EPS $1.08 Misses $1.19 Estimate

Plumas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBC#NASDAQ">PLBC</a>) reported quarterly earnings of $1.05 per share which missed the analyst consensus estimate of $1.19 by 11.76 percent.

Earnings Misses

Plumas Q1 2024 EPS $1.05 Misses $1.19 Estimate

Tuesday marks the last chance for investors to receive the next dividend payout from Plumas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBC#NASDAQ">PLBC</a>). 
<h3>What's Happening</h3>
The company announced on Thursday that it would pay shareholders a quarterly dividend of 27 cents per share. On Wednesday, Plumas will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 27 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Wednesday. Shareholders who own PLBC as of the end of Tuesday's session are eligible to receive the 27 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on February 15, 2024. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
<a href="https://www.benzinga.com/quote/PLBC">Track real-time stock fluctuations for Plumas on Benzinga.</a>

Dividends

Plumas: Dividend Insights

Raymond James analyst David Feaster maintains Plumas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBC#NASDAQ">PLBC</a>) with a Outperform and raises the price target from $38 to $40.

Raymond James Maintains Outperform on Plumas, Raises Price Target to $40

Plumas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBC#NASDAQ">PLBC</a>) reported its Q4 earnings results on Wednesday, January 17, 2024 at 09:00 AM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Plumas beat estimated earnings by 3.25%, reporting an EPS of $1.27 versus an estimate of $1.23.
Revenue was up $477 thousand from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.12 which was followed by a 3.07% drop in the share price the next day.

&#x2A;&#x2A; Listen to the earnings announcement yourself by <a href="">clicking here</a>. &#x2A;&#x2A;
To track all earnings releases for Plumas <a href="https://www.benzinga.com/quote/PLBC/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: Plumas Q4 Earnings

Plumas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBC#NASDAQ">PLBC</a>) reported quarterly earnings of $1.27 per share which beat the analyst consensus estimate of $1.23 by 3.25 percent.

Earnings Beats

Plumas Q4 2023 GAAP EPS $1.27 Beats $1.23 Estimate

Monday marks the last chance for investors to receive the next dividend payout from Plumas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBC#NASDAQ">PLBC</a>). 
<h3>What's Happening</h3>
The company announced on Thursday that it would pay shareholders a quarterly dividend of 25 cents per share. On Tuesday, Plumas will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 25 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Tuesday. Shareholders who own PLBC as of the end of Monday's session are eligible to receive the 25 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on November 15, 2023. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
To read more news on Plumas <a href="https://www.benzinga.com/stock//">click here</a>
<a href="https://www.benzinga.com/calendars/dividends">Click here</a> to visit our Dividends Calendar.

Plumas's Ex-Dividend Date Is Tuesday, Here's What You Need To Know

Plumas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBC#NASDAQ">PLBC</a>) reported quarterly earnings of $1.34 per share which beat the analyst consensus estimate of $1.22 by 9.84 percent. This is a 8.94 percent increase over earnings of $1.23 per share from the same period last year.

Plumas Q3 EPS $1.34

<h3>Upgrades</h3>
Jefferies upgraded the previous rating for Mesoblast Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>) from Hold to Buy. NoneThe current stock performance of Mesoblast shows a 52-week-high of $5.12 and a 52-week-low of $1.16. Moreover, at the end of the last trading period, the closing price was at $1.43. 
Argus Research upgraded the previous rating for Oshkosh Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSK#NYSE">OSK</a>) from Hold to Buy. For the second quarter, Oshkosh had an EPS of $2.69, compared to year-ago quarter EPS of $0.41. The stock has a 52-week-high of $106.66 and a 52-week-low of $69.31. At the end of the last trading period, Oshkosh closed at $103.23. 
Evercore ISI Group upgraded the previous rating for Okta Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) from Underperform to In-Line. For the second quarter, Okta had an EPS of $0.31, compared to year-ago quarter EPS of $0.10. The stock has a 52-week-high of $94.64 and a 52-week-low of $44.13. At the end of the last trading period, Okta closed at $73.57. 
For Shopify Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>), Canaccord Genuity upgraded the previous rating of Hold to Buy. Shopify earned $0.14 in the second quarter, compared to $0.03 in the year-ago quarter. The current stock performance of Shopify shows a 52-week-high of $71.43 and a 52-week-low of $23.64. Moreover, at the end of the last trading period, the closing price was at $60.01. 
BMO Capital upgraded the previous rating for The Hanover Insurance Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THG#NYSE">THG</a>) from Market Perform to Outperform. Hanover Insurance Gr earned $1.91 in the second quarter, compared to $2.32 in the year-ago quarter. The stock has a 52-week-high of $148.78 and a 52-week-low of $103.90. At the end of the last trading period, Hanover Insurance Gr closed at $106.00. 
Citigroup upgraded the previous rating for Arista Networks Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) from Neutral to Buy. In the second quarter, Arista Networks showed an EPS of $1.58, compared to $1.08 from the year-ago quarter. At the moment, the stock has a 52-week-high of $193.91 and a 52-week-low of $98.72. Arista Networks closed at $187.10 at the end of the last trading period. 
For Guidewire Software Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>), Wells Fargo upgraded the previous rating of Underweight to Equal-Weight. For the third quarter, Guidewire Software had an EPS of $0.08, compared to year-ago quarter EPS of $0.26. At the moment, the stock has a 52-week-high of $86.79 and a 52-week-low of $52.19. Guidewire Software closed at $83.80 at the end of the last trading period. 
Redburn Partners upgraded the previous rating for Exxon Mobil Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) from Sell to Neutral. Exxon Mobil earned $1.94 in the second quarter, compared to $4.14 in the year-ago quarter. At the moment, the stock has a 52-week-high of $119.92 and a 52-week-low of $83.89. Exxon Mobil closed at $110.88 at the end of the last trading period. 
According to Raymond James, the prior rating for SkyWest Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYW#NASDAQ">SKYW</a>) was changed from Market Perform to Outperform. In the second quarter, SkyWest showed an EPS of $0.35, compared to $1.07 from the year-ago quarter. The current stock performance of SkyWest shows a 52-week-high of $45.98 and a 52-week-low of $14.76. Moreover, at the end of the last trading period, the closing price was at $41.40. 
For 3M Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>), Morgan Stanley upgraded the previous rating of Underweight to Equal-Weight. 3M earned $2.17 in the second quarter, compared to $2.48 in the year-ago quarter. The current stock performance of 3M shows a 52-week-high of $133.89 and a 52-week-low of $92.38. Moreover, at the end of the last trading period, the closing price was at $104.45. 
JP Morgan upgraded the previous rating for Vasta Platform Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTA#NASDAQ">VSTA</a>) from Neutral to Overweight. Vasta Platform earned $0.20 in the second quarter, compared to $0.18 in the year-ago quarter. The current stock performance of Vasta Platform shows a 52-week-high of $5.60 and a 52-week-low of $3.05. Moreover, at the end of the last trading period, the closing price was at $3.66. 
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings upgrades.</a>
<h3>Downgrades</h3>
Chardan Capital downgraded the previous rating for Outlook Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTLK#NASDAQ">OTLK</a>) from Buy to Neutral. For the third quarter, Outlook Therapeutics had an EPS of $0.08, compared to year-ago quarter EPS of $0.08. The current stock performance of Outlook Therapeutics shows a 52-week-high of $2.03 and a 52-week-low of $0.21. Moreover, at the end of the last trading period, the closing price was at $0.27. 
Oppenheimer downgraded the previous rating for Dollar General Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) from Outperform to Perform. In the second quarter, Dollar Gen showed an EPS of $2.13, compared to $2.98 from the year-ago quarter. The stock has a 52-week-high of $261.57 and a 52-week-low of $151.27. At the end of the last trading period, Dollar Gen closed at $157.66. 
Susquehanna downgraded the previous rating for C.H. Robinson Worldwide Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRW#NASDAQ">CHRW</a>) from Neutral to Negative. In the second quarter, C.H. Robinson Worldwide showed an EPS of $0.90, compared to $2.52 from the year-ago quarter. The stock has a 52-week-high of $116.76 and a 52-week-low of $86.63. At the end of the last trading period, C.H. Robinson Worldwide closed at $94.63. 
Susquehanna downgraded the previous rating for RXO Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RXO#NYSE">RXO</a>) from Neutral to Negative. In the second quarter, RXO showed an EPS of $0.08, compared to $0.56 from the year-ago quarter. At the moment, the stock has a 52-week-high of $23.74 and a 52-week-low of $14.75. RXO closed at $18.81 at the end of the last trading period. 
For Outlook Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTLK#NASDAQ">OTLK</a>), HC Wainwright &amp; Co. downgraded the previous rating of Buy to Neutral. In the third quarter, Outlook Therapeutics showed an EPS of $0.08, compared to $0.08 from the year-ago quarter. The stock has a 52-week-high of $2.03 and a 52-week-low of $0.21. At the end of the last trading period, Outlook Therapeutics closed at $0.27. 
According to Wells Fargo, the prior rating for Victoria's Secret &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSCO#NYSE">VSCO</a>) was changed from Overweight to Equal-Weight. In the second quarter, Victoria's Secret showed an EPS of $0.24, compared to $1.09 from the year-ago quarter. The current stock performance of Victoria's Secret shows a 52-week-high of $48.12 and a 52-week-low of $16.78. Moreover, at the end of the last trading period, the closing price was at $17.94. 
Evercore ISI Group downgraded the previous rating for Chewy Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) from Outperform to In-Line. In the second quarter, Chewy showed an EPS of $0.15, compared to $0.05 from the year-ago quarter. The current stock performance of Chewy shows a 52-week-high of $52.88 and a 52-week-low of $25.29. Moreover, at the end of the last trading period, the closing price was at $27.33. 
CLSA downgraded the previous rating for Gaotu Techedu Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOTU#NYSE">GOTU</a>) from Outperform to Underperform. Gaotu Techedu earned $0.03 in the second quarter, compared to $0.00 in the year-ago quarter. At the moment, the stock has a 52-week-high of $5.49 and a 52-week-low of $0.64. Gaotu Techedu closed at $3.24 at the end of the last trading period. 
JP Morgan downgraded the previous rating for Hostess Brands Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWNK#NASDAQ">TWNK</a>) from Overweight to Neutral. Hostess Brands earned $0.28 in the second quarter, compared to $0.22 in the year-ago quarter. The stock has a 52-week-high of $28.97 and a 52-week-low of $21.59. At the end of the last trading period, Hostess Brands closed at $28.06. 
For Medical Properties Trust Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>), Mizuho downgraded the previous rating of Buy to Neutral. In the second quarter, Medical Properties Trust showed an EPS of $0.48, compared to $0.46 from the year-ago quarter. At the moment, the stock has a 52-week-high of $15.15 and a 52-week-low of $6.38. Medical Properties Trust closed at $7.34 at the end of the last trading period. 
Morgan Stanley downgraded the previous rating for Palantir Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) from Equal-Weight to Underweight. Palantir Technologies earned $0.05 in the second quarter, compared to $0.01 in the year-ago quarter. The current stock performance of Palantir Technologies shows a 52-week-high of $20.24 and a 52-week-low of $5.84. Moreover, at the end of the last trading period, the closing price was at $16.33. 
According to B. Riley Securities, the prior rating for MasterCraft Boat Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCFT#NASDAQ">MCFT</a>) was changed from Buy to Neutral. In the fourth quarter, MasterCraft Boat Hldgs showed an EPS of $1.37, compared to $1.92 from the year-ago quarter. The current stock performance of MasterCraft Boat Hldgs shows a 52-week-high of $35.29 and a 52-week-low of $18.49. Moreover, at the end of the last trading period, the closing price was at $21.76. 
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings downgrades.</a>
<h3>Initiations</h3>
Raymond James initiated coverage on Middlefield Banc Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBCN#NASDAQ">MBCN</a>) with a Market Perform rating. For the second quarter, Middlefield Banc had an EPS of $0.63, compared to year-ago quarter EPS of $0.70. The stock has a 52-week-high of $30.21 and a 52-week-low of $22.09. At the end of the last trading period, Middlefield Banc closed at $26.99. 
Raymond James initiated coverage on Flushing Financial Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIC#NASDAQ">FFIC</a>) with an Outperform rating. The price target for Flushing Financial is set to $17.00. In the second quarter, Flushing Financial showed an EPS of $0.26, compared to $0.70 from the year-ago quarter. The current stock performance of Flushing Financial shows a 52-week-high of $21.55 and a 52-week-low of $9.28. Moreover, at the end of the last trading period, the closing price was at $14.04. 
With an Outperform rating, Raymond James initiated coverage on Plumas Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBC#NASDAQ">PLBC</a>). The price target seems to have been set at $38.00 for Plumas. In the second quarter, Plumas showed an EPS of $1.12, compared to $0.96 from the year-ago quarter. The stock has a 52-week-high of $45.31 and a 52-week-low of $27.50. At the end of the last trading period, Plumas closed at $34.71. 
With a Buy rating, Truist Securities initiated coverage on RadNet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDNT#NASDAQ">RDNT</a>). The price target seems to have been set at $40.00 for RadNet. For the second quarter, RadNet had an EPS of $0.24, compared to year-ago quarter EPS of $0.15. The stock has a 52-week-high of $35.18 and a 52-week-low of $12.14. At the end of the last trading period, RadNet closed at $33.01. 
Janney Montgomery Scott initiated coverage on Microvast Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVST#NASDAQ">MVST</a>) with a Buy rating. The price target for Microvast Holdings is set to $8.00. For the second quarter, Microvast Holdings had an EPS of $0.02, compared to year-ago quarter EPS of $0.05. At the moment, the stock has a 52-week-high of $2.91 and a 52-week-low of $0.88. Microvast Holdings closed at $1.81 at the end of the last trading period. 
BMO Capital initiated coverage on Civitas Resources Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIVI#NYSE">CIVI</a>) with an Outperform rating. The price target for Civitas Resources is set to $95.00. Civitas Resources earned $1.72 in the second quarter, compared to $4.63 in the year-ago quarter. The stock has a 52-week-high of $81.63 and a 52-week-low of $52.77. At the end of the last trading period, Civitas Resources closed at $81.28. 
BMO Capital initiated coverage on Chord Energy Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRD#NASDAQ">CHRD</a>) with an Outperform rating. The price target for Chord Energy is set to $185.00. In the second quarter, Chord Energy showed an EPS of $3.65, compared to $7.30 from the year-ago quarter. At the moment, the stock has a 52-week-high of $164.79 and a 52-week-low of $117.05. Chord Energy closed at $158.66 at the end of the last trading period. 
HC Wainwright &amp; Co. initiated coverage on Lyra Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYRA#NASDAQ">LYRA</a>) with a Buy rating. The price target for Lyra Therapeutics is set to $12.00. In the second quarter, Lyra Therapeutics showed an EPS of $0.36, compared to $0.43 from the year-ago quarter. The current stock performance of Lyra Therapeutics shows a 52-week-high of $6.37 and a 52-week-low of $1.86. Moreover, at the end of the last trading period, the closing price was at $3.36. 
With a Buy rating, Needham initiated coverage on MoonLake Immunotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLTX#NASDAQ">MLTX</a>). The price target seems to have been set at $76.00 for MoonLake. For the second quarter, MoonLake had an EPS of $0.23, compared to year-ago quarter EPS of $0.34. The stock has a 52-week-high of $63.40 and a 52-week-low of $7.05. At the end of the last trading period, MoonLake closed at $56.19. 
With an Overweight rating, JP Morgan initiated coverage on MP Materials Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>). The price target seems to have been set at $27.00 for MP Materials. In the second quarter, MP Materials showed an EPS of $0.09, compared to $0.41 from the year-ago quarter. The current stock performance of MP Materials shows a 52-week-high of $36.67 and a 52-week-low of $19.18. Moreover, at the end of the last trading period, the closing price was at $20.33. 
JP Morgan initiated coverage on Establishment Labs Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESTA#NASDAQ">ESTA</a>) with an Overweight rating. The price target for Establishment Labs Hldgs is set to $75.00. In the second quarter, Establishment Labs Hldgs showed an EPS of $0.65, compared to $1.52 from the year-ago quarter. At the moment, the stock has a 52-week-high of $79.88 and a 52-week-low of $44.48. Establishment Labs Hldgs closed at $58.09 at the end of the last trading period. 
With an Outperform rating, Oppenheimer initiated coverage on Crinetics Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRNX#NASDAQ">CRNX</a>). The price target seems to have been set at $40.00 for Crinetics Pharmaceuticals. In the second quarter, Crinetics Pharmaceuticals showed an EPS of $0.94, compared to $0.81 from the year-ago quarter. The current stock performance of Crinetics Pharmaceuticals shows a 52-week-high of $24.58 and a 52-week-low of $15.23. Moreover, at the end of the last trading period, the closing price was at $16.52. 
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings initiations.</a>

Upgrades

Downgrades

Intraday Update

ANET

CHRD

CHRW

CHWY

CIVI

CRNX

ESTA

FFIC

GSX Techedu Inc. American Depositary Shares

GOTU

GWRE

LYRA

MBCN

MCFT

MESO

MLTX

MVST

OKTA

OTLK

PLTR

RDNT

SHOP

SKYW

Hostess Brands, Inc. - Class A Common Stock

TWNK

VSCO

VSTA

Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2023

Raymond James analyst David Feaster initiates coverage on Plumas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBC#NASDAQ">PLBC</a>) with a Outperform rating and announces Price Target of $38.

Raymond James Initiates Coverage On Plumas with Outperform Rating, Announces Price Target of $38

Friday marks the last chance for investors to receive the next dividend payout from Plumas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBC#NASDAQ">PLBC</a>). 
<h3>What's Happening</h3>
The company announced on Thursday that it would pay shareholders a quarterly dividend of 25 cents per share. On Monday, Plumas will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 25 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Monday. Shareholders who own PLBC as of the end of Friday's session are eligible to receive the 25 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on August 15, 2023. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
<a href="https://www.benzinga.com/quote/PLBC">Monitor live stock price updates for Plumas on Benzinga.</a>

Friday Is Your Last Chance To Buy Plumas Before The Dividend Payout

&nbsp;Plumas Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBC#NASDAQ">PLBC</a>), the parent company of Plumas Bank, today announced that Plumas Bancorp (&quot;Company&quot;) has been included in the Russell 2000 Index by FTSE Russell following its annual reconstitution. The announcement was made after the U.S. stock market closed on June 23, 2023. 
&nbsp;
Andrew J. Ryback, director, president and chief executive officer of Plumas Bancorp and Plumas Bank stated, &quot;Inclusion on the Russell 2000 provides meaningful exposure in the investment community with a multitude of funds benchmarked to the Russell. With Plumas&#39; return to the index, we anticipate enhanced liquidity in our stock and broadening of our shareholder base.&quot;
Russell determines inclusion of companies in its equity indexes by market-capitalization rankings and style attributes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Plumas Bancorp previously listed on the Russell 2000 in 2020, rolling off in 2021 due to changes in the market cap threshold for listing.

Plumas Bancorp Announces It Has Been Included In The Russell 2000 Index

Thursday marks the last chance for investors to receive the next dividend payout from Plumas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBC#NASDAQ">PLBC</a>). 
<h3>What's Happening</h3>
The company announced on Thursday that it would pay shareholders a quarterly dividend of 25 cents per share. On Friday, Plumas will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 25 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Friday. Shareholders who own PLBC as of the end of Thursday's session are eligible to receive the 25 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on May 15, 2023. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
To read more news on Plumas <a href="https://www.benzinga.com/stock//">click here</a>
<a href="https://www.benzinga.com/calendars/dividends">Click here</a> to visit our Dividends Calendar.

Plumas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBC#NASDAQ">PLBC</a>) reported quarterly earnings of $1.28 per share. This is a 31.96 percent increase over earnings of $0.97 per share from the same period last year.

Plumas Q1 EPS $1.28 Up From $0.97 YoY

Plumas Bancorp declares $0.27 dividend

Richmond Mutual Bancorporation: Time To Take Profits

Plumas Bancorp (PLBC) has issued an announcement. Plumas Bank and Mountainseed Real Estate Services, LLC have mutually agreed to cancel their previ...

Plumas Bancorp Cancels Property Deal with Mountainseed

Plumas Bancorp ( ($PLBC) ) has shared an announcement. Plumas Bancorp has released a presentation for future investor discussions, emphasizing that...

Plumas Bancorp Shares Investor Presentation Highlights

Plumas Bancorp GAAP EPS of $1.31 beats by $0.17

Plumas Bancorp: Loan Growth May Offset Net Interest Margin Compression

Parke Bancorp: Still Banking On This Name

Stephens initiated coverage of Plumas Bancorp (PLBC) with an Overweight rating and $60 price target Published first on TheFly – the ultimate source...

Plumas Bancorp initiated with an Overweight at Stephens

As previously reported, Stephens analyst Andrew Terrell initiated coverage of Plumas Bancorp (PLBC) with an Overweight rating and $60 price target ...

Comments

Plumas

空売り

Plumas (NASDAQ:PLBC) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル